Public Profile

Antares Pharma, Inc.

Antares Pharma, Inc., a leading player in the pharmaceutical industry, is headquartered in the United States. Founded in 1978, the company has established itself as a pioneer in the development of innovative drug delivery systems, particularly in the areas of injectable pharmaceuticals. With a focus on enhancing patient compliance and improving therapeutic outcomes, Antares Pharma offers a range of unique products, including its proprietary auto-injector technology and transdermal delivery systems. The company has achieved significant milestones, including partnerships with major pharmaceutical firms and the successful launch of several key products. Antares Pharma's commitment to innovation and quality has positioned it as a trusted name in the market, making substantial contributions to the fields of endocrinology, pain management, and other therapeutic areas.

DitchCarbon Score

How does Antares Pharma, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Antares Pharma, Inc.'s score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Antares Pharma, Inc.'s reported carbon emissions

Antares Pharma, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the absence of documented reduction initiatives or climate pledges suggests that the company may still be in the early stages of developing a comprehensive sustainability strategy. As the industry increasingly prioritises climate action, it will be essential for Antares Pharma to establish measurable targets and commitments to align with global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Antares Pharma, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Antares Pharma, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Antares Pharma, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Pfizer

US
Pharmaceutical Preparation Manufacturing
Updated about 14 hours ago

Bms

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Hospira

US
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Glaxosmithkline

GB
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Owen Mumford

GB
Health and social work services (85)
Updated 4 days ago

Vascular Solutions, Inc.

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 months ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers